Novel oral glucose-lowering drugs are associated with lower risk of all-cause mortality, cardiovascular events and severe hypoglycaemia compared with insulin in patients with type 2 diabetes
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Marcus Thuresson Johan Bodegard Jan W Eriksson Anna Norhammar |
| Publication date | January 24, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |